Search Result For "targeted cancer therapy"
Brand No available data!
Generic No available data
Generic Name : Brentuximab vedotin
Indication : Previously untreated CD30+ Stage IV Hodgkin lymphoma (HL) in combination w/ doxorubicin, vinblastine & dacarbazine. CD30+ HL in patients at increased risk of relapse or progression following autol...
Manufacturer : Takeda
Generic Name : Everolimus
Indication : Hormone receptor-positive & HER2/neu negative advanced breast cancer, in combination w/ exemestane, in postmenopausal women w/o symptomatic visceral disease after recurrence or progression followi...
Manufacturer : Novartis
Distributor : Four Star / Zuellig
Generic Name : Alectinib
Indication : Anaplastic lymphoma kinase (ALK)-positive, metastatic NSCLC.
Manufacturer : Roche
Generic Name : Brigatinib
Indication : Monotherapy for the treatment of adult patients w/ anaplastic lymphoma kinase (ALK)‑positive advanced non‑small cell lung cancer (NSCLC) previously not treated w/ an ALK inhibitor. Monotherapy for the...
Manufacturer : Takeda
Generic Name : Gefitinib
Indication : 1st line treatment of patients w/ locally advanced (not amenable to curative therapy) or metastatic NSCLC who have activating mutations of the EGFR-TK.
Manufacturer : Apotex
Distributor : Hind Wing
Generic Name : Bevacizumab
Indication : In combination w/ fluoropyrimidine-based chemotherapy for treatment of metastatic colorectal cancer (mCRC). In combination w/ paclitaxel for 1st-line treatment of metastatic breast cancer (mBC). In ad...
Manufacturer : Roche
Generic Name : Avapritinib
Indication : Monotherapy for the treatment of adults w/ unresectable or metastatic GI stromal tumours harbouring the platelet-derived growth factor receptor α D842V mutation.
Manufacturer : CStone
Generic Name : Erdafitinib
Indication : Treatment of adult patients w/ locally advanced or metastatic urothelial carcinoma (mUC), that has susceptible FGFR3 or FGFR2 genetic alterations, & progressed during or following at least 1 line ...
Manufacturer : Janssen
Generic Name : Belantamab mafodotin
Indication : Monotherapy for the treatment of multiple myeloma in adults, who have received at least 4 prior therapies & whose disease is refractory to at least 1 proteasome inhibitor, 1 immunomodulatory agent...
Manufacturer : GlaxoSmithKline
Distributor : Zuellig

No search result found for "targeted cancer therapy"
Some things you can do
  • Check for spelling mistake.
  • Try searching in Find Drug Company.
  • Try browsing by MIMS Class.
  • Try different keywords.
  • Try more general keywords.
  • Try fewer keywords.
Go to Advanced Search

No search result found for "targeted cancer therapy"
Some things you can do
  • Check for spelling mistake.
  • Try searching in Find Drug Company.
  • Try browsing by MIMS Class.
  • Try different keywords.
  • Try more general keywords.
  • Try fewer keywords.
Go to Advanced Search

Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in